Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.655    0.005 (0.11%)
Bid:
4.61
Ask:
4.68
Spread: 0.07 (1.518%)
Market Cap: £223.42m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Directorate Changes

3 Jan 2012 07:00

RNS Number : 8382U
Seeing Machines Limited
03 January 2012
 



 

3 January 2012

Seeing Machines Limited

 

("Seeing Machines" or the "Company")

 

Directorate Changes

 

Seeing Machines Limited (AIM: SEE), a leading developer of facial image processing software for applications that rely on understanding the movement of human faces and eyes, announces today the appointment of Kenneth (Ken) Kroeger to the board of Seeing Machines as Managing Director and the resignation of past Chairman William (Bill) Mobbs as a director of the Company. Mr Mobbs resignation takes effect from the 31st of December 2011 and Mr Kroeger's appointment is with immediate effect.

 

Bill Mobbs who joined the board of the Company in 2006 and took over as Chairman in 2009 leaves the board to concentrate on his other business interests.

 

Ken Kroeger, aged 50, is a successful technology entrepreneur who founded Catalyst Interactive, an internationally recognised 3-D simulation and training provider (later acquired by KBR). At Catalyst Interactive, Ken grew the organisation from inception to an international business through technical innovation and sound leadership.

 

Ken's background in technology, research and development, business management and sales has provided Seeing Machines with a strong commercial focus since his appointment as CEO in July 2011.

 

David Gaul, the current Chairman of the Company commented:

 

"The Company is delighted that Ken has joined the board and the directors are already aware that he brings a wealth of industry knowledge and experience which will prove invaluable to Seeing Machines. The Company wishes to express its sincere thanks to Bill Mobbs for his significant contribution to the Company over the last 5 years."

 

Save for the above, the following information, pursuant to AIM Rule 17, Schedule Two (g) is disclosed in respect of the appointment of Ken:

 

Current Appointments:

Travelok Pty LtdHealthcube Management Pty LtdHealthcube Pty LtdKroeger Nominees Pty LtdLighthouse Business Innovation Centre LimitedConnexions Pty LtdContact Action Pty LtdInsperience Pty Ltd

Past Appointments:

Catalyst Interactive Pty LtdEqual Access Testing Pty Ltd

Mr Kroeger is not currently interested in the total issued share capital of the Company.

 

 

 

 

Enquiries:

 

Seeing Machines Limited

Ken Kroeger, Managing Director & CEO

+61 (0) 2 6103 4700

 

Daniel Stewart & Company plc(Nomad & Broker)

David Hart/James Thomas

+44 (0) 20 7776 6550

 

Walbrook PR Ltd

+44 (0) 20 7933 8780

Bob Huxford

bob.huxford@walbrookpr.com

Helen Westaway

helen.westaway@walbrookpr.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGUMAGUPPGUP
Date   Source Headline
11th Mar 20097:00 amRNSReviewed Interim Results
18th Feb 20097:00 amRNSRestructuring of the business
28th Jan 20099:41 amRNSTrading update and notice of results
1st Dec 20088:14 amRNSChange of Registered Office
27th Nov 20088:08 amRNSResult of AGM
29th Oct 200810:52 amRNSNotice of AGM
23rd Sep 20087:00 amRNSFinal Results
17th Sep 20088:37 amRNSNotice of Final Results
26th Aug 20088:33 amRNSNEW FACEAPI PRODUCT RELEASE
23rd Jul 20087:37 amRNSFirst Expected Profit Report
7th May 20088:08 amRNSNORTH AMERICAN OPERATION
7th Apr 200812:00 pmRNSChange of Broker
4th Mar 20087:59 amRNSInterim Results
4th Mar 20087:51 amRNSMajor contract gain
13th Feb 20088:27 amRNSHolding in Company
28th Dec 20079:11 amRNSAnnual Report
11th Dec 200710:54 amRNSChange of Adviser
29th Nov 200710:03 amRNSAGM Results
8th Nov 200712:38 pmRNSDirector/PDMR Shareholding
8th Nov 200712:34 pmRNSGlaucoma Device at AAO
31st Oct 20079:26 amRNSCompletion of Placing-Replace
31st Oct 20077:01 amRNSCompletion of Placing
26th Oct 20079:35 amRNSShareholder Approval
17th Oct 20072:21 pmRNSDirector/PDMR Shareholding
15th Oct 20079:23 amRNSCFO Appointment
25th Sep 200710:23 amRNSFurther Placing
24th Sep 20071:12 pmRNSFinal Results
24th Sep 20071:00 pmRNSFundraising
15th Aug 200712:43 pmRNSAIM Rule 26 Compliance
15th Aug 20079:27 amRNSFDA Approval for Truefield
2nd Jul 20077:01 amRNSNew Product Releases
29th Jun 200710:11 amRNSMaster License Agreement
22nd May 200711:15 amRNSLicensing agreement signed
8th May 20077:02 amRNSGlaucoma Device Demonstrated
28th Mar 20072:40 pmRNSInterim Results
14th Mar 200710:45 amRNSAward win for glaucoma device
12th Mar 20077:02 amRNSAddition to product released
19th Dec 200610:06 amRNSTotal Voting Rights
30th Nov 20068:27 amRNSAGM Statement
9th Nov 20067:01 amRNSGlaucoma Study Re-commences
2nd Nov 20067:01 amRNSNew Product
19th Oct 20065:38 pmRNSFinal Results - Replacement
19th Oct 200611:29 amRNSFinal Results
18th Oct 200611:04 amRNSDirectorate Change
17th Oct 20063:20 pmRNSNew Version of faceLAB
21st Sep 20064:41 pmRNSIssue of Equity
18th Sep 200611:24 amRNSAutomotive progress
18th Sep 20069:45 amRNSGlaucoma Grant Signed
30th Aug 200611:46 amRNSClinical Study Results
14th Aug 200610:57 amRNSGrant Approval

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.